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308Objectives: Functional tricuspid regurgitation (FTR) worsens over time, and its natural history is unfavorable.
An aggressive surgical strategy, using the echocardiographic systolic dimensions of the tricuspid annulus
(sysTA), can be helpful to reduce the detrimental late effects of FTR.
Methods: FromMarch 2006 to February 2008, 298 patients, with at least FTR grade 1þ, underwent mitral valve
surgery. Of these 298 patients, 167 underwent tricuspid repair (treated group [T], moderate-or-greater FTR in
108 and mild in 59, with sysTA>24 mm) and 137 did not (untreated group [UT], moderate-or-greater FTR
in 16 and mild in 115; 81 with sysTA>24 mm and 34 with sysTA of  24 mm). The 256 survivors underwent
echocardiographic examination at a mean follow-up of 13  8 months.
Results: Preoperatively, at discharge, and at the follow-up examination, the mean FTR grade was 1.11  0.32,
0.87 0.49, and 1.03 0.57 (P¼NS) in the UT group and 2.11 0.92, 0.45 0.36, and 0.48 0.32 (P<.001)
in the T group. A total of 24 patients had FTR grade 2 or greater, 16 (14.5%) in the UT group and 8 (5.5%) in the
T group (P¼ .026). In the UT group, 10 of 16 patients had sysTA of 25 to 28 mm and 6 of 10 had sysTA greater
than 28 mm. No patient with mild FTR and sysTA of 24 mm or less had an increased FTR grade. Globally, 12
patients (10.9%) had an increased FTR grade in the UT group versus none in the T group (P<.001). Patients
with postoperative atrial fibrillation had less residual FTR if annuloplasty had been performed (1.6 0.7 vs 0.91
 0.63, P ¼ .005).
Conclusions: An aggressive strategy for FTR correction, using the sysTA, was able to reduce the FTR grade
1 year after surgery, but mitral surgery alone could not. (J Thorac Cardiovasc Surg 2011;142:308-13)Functional tricuspid regurgitation (FTR) is an often
neglected disease that only recently has been considered
worthy of attention by surgeons. Nevertheless, no clear con-
sensus has been reached on when FTR should be corrected
and how it should be corrected. In addition, the early return
of FTR is an issue that has made surgeons reluctant to
expand FTR repair.
The natural history of FTR is not favorable. Nath and col-
leagues1 found that the survival of patients with moderate or
severe FTR was significantly reduced compared with the
survival of patients without or with only mild FTR. Dreyfus
and colleagues2 emphasized that FTR that is even less than
mild, if left untreated, can worsen by 2 grades after close to 5
years postoperatively. Because of these studies, we decided
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The Journal of Thoracic and Cardiovascular Surgvalve (MV) surgery, according to the echocardiographic
systolic dimension of the tricuspid annulus (sysTA). In the
present study, we report our experience to evaluate the mid-
term results of our surgical strategy and to standardize the
principles of surgical treatment.
MATERIALS AND METHODS
Population
From March 2006 to February 2008, 298 patients with at least FTR of
grade 1 underwent MV surgery. Of these 298 patients, 198 underwent re-
pair (66.4%) and 100 underwent replacement (33.6%) at a single center.
In addition, 167 of these patients (56.0%) underwent tricuspid repair for
FTR (treated [T] group), and 131 (44%) did not (untreated [UT] group).
The preoperative characteristics of the patients are listed in Table 1. The
etiology of MV disease was mainly functional in the UT group (57.7%
vs 33.0%, P<.001) and the incidence of atrial fibrillation was greater in
the T group (46.1% vs 13.7%, P<.001). The echocardiographic values,
as expected, were different between the 2 groups (Table 1).
During follow-up, those patients who showed any sign of repair failure,
prosthetic malfunction, or severe impairment of left ventricular function,
events that could justify the development of additional FTR, were excluded
from the present study (n ¼ 15).
Echocardiographic Evaluation
All the patients underwent transthoracic echocardiography preopera-
tively. The tricuspid valve (TV) was evaluated, and the following data
were recorded: tricuspid annulus (TA) diameter (apical 4-chamber view)
in systole and diastole, the tenting area, and the TV coaptation depth.
The severity of FTR, as assessed by Doppler echocardiography, was graded
on a scale from 1 to 4 (1, mild; 2, moderate; 3, moderate to severe; and 4,ery c August 2011
Abbreviations and Acronyms
CI ¼ confidence interval
FTR ¼ functional tricuspid regurgitation
HR ¼ hazard ratio
MV ¼ mitral valve
sysTA ¼ systolic dimensions of the tricuspid
annulus
T ¼ treated
TA ¼ tricuspid annulus
TR ¼ tricuspid regurgitation
TV ¼ tricuspid valve
UT ¼ untreated
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the tricuspid annular peak systolic excursion. The right ventricular systolic
pressures were estimated using continuous-wave Doppler data and the sim-
plified Bernoulli equation (4 3 [peak tricuspid regurgitation [TR] veloc-
ity]2), with 10 mm Hg added for the estimated right atrial pressure. The
value obtained was considered the systolic pulmonary artery pressure.
Also, 20 volunteers were evaluated to have normal echocardiographic
values as a reference (Table 2).
Surgical Indications
Patients with an FTR grade of moderate or greater were always treated.
In addition, 16 patients underwent FTR treatment by surgeon choice (be-
cause of undergrading during perioperative transesophageal echocardiog-
raphy). Mild FTR was always treated in the T group when the sysTA
was greater than 24 mm (median value of normal). Patients with a sysTA
of 24 mm or less were not treated, and all had had mild FTR. Thus, the
UT group included 131 patients, 115 with mild FTR (81 with sysTA>
24 mm but not treated because not all the surgeons agreed to treat mild
FTR, and 34 with sysTA of  24 mm) and 16 patients with moderate or
greater FTR. The T group included 59 patients with mild FTR and sysTA
greater than 24 mm and 108 patients with moderate or greater FTR.
Surgical Details
All patients underwent surgery with cardiopulmonary bypass and
intermittent antegrade/retrograde warm blood cardioplegia. A median
sternotomy was used in every case.
Themitral valvewas replaced in 100 patients (39 in the UT group and 61
in the T group, P ¼ .222) and was repaired in the remaining patients. Ab-
lation of atrial fibrillation was performed in 47 patients (4 in the UT group
and 43 in the T group, P ¼ .021).
DeVega annuloplastywas performed, starting twice from the anterosep-
tal commissure and ending twice at the level of the septal annulus in front of
the coronary sinus, using 2-0 Ethibond and not monofilament suture. We
extended the correction beyond the posteroseptal commissure because
the septal leaflet insertion near this commissure is a part of the free wall,
which can dilate.5 The final orifice was gauged to a No. 25 cylindrical pros-
thetic sizer. The technique used for band annuloplasty has been previously
described.6 In brief, the first suture was positioned starting from the ante-
roseptal commissure and the last one at the septal annulus, 28.5 mm distant
from the first suture and roughly in front of the coronary sinus. The band
was 50 mm long (SMB50, Sorin, Saluggia, Italy), and the final circumfer-
ence was 78.5 mm (the circumference of a No. 25 sizer).
From March 2006 to June 2008, all patients underwent double-
pledgeted De Vega suture annuloplasty. Since June 2008, some patients
with an enlarged TA underwent band annuloplasty (n ¼ 25). Over time,The Journal of Thoracic and Cathe indications became better specified; the current indications are listed
in Table 3. De Vega suture annuloplasty was reserved for patients with
sysTA, in systole, up to 28 mm (the maximal systolic value of the sysTA
in normal patients), and band annuloplasty was used when the sysTA
was larger than 28 mm. Ultimately, the indications for which technique
of annuloplasty to use depend on the sysTA dimensions and not on the
FTR grade.
Follow-up
All the surviving patients were followed up at our outpatient clinic and
underwent an echocardiographic examination after a mean of 13  8
months. The follow-up period ended in March 2009 and was 100% com-
plete. The median follow-up time was 22 months (interquartile range,
13–37 months), without any difference between the 2 groups.
Statistical Analysis
The results are expressed as themean standard deviation in the case of
normally distributed continuous variables. In the case of categorical vari-
ables, the counts and percentages are reported. Statistical analysis compar-
ing the 2 groups was performed using the unpaired 2-tailed t test for
continuous normally distributed variables, with the Mann-Whitney U test
for continuous non-normally distributed variables and Pearson’s
chi-square test (or Fisher’s exact test) for categorical variables. The pre-
and postoperative data within each group were compared using a paired t
test. The 2-year actuarial outcome was evaluated using the Kaplan-Meier
method. Cox analysis was performed to identify the risk factors for FTR
recurrence, considered as moderate or greater FTR at the follow-up exam-
ination. The results are reported as the hazard ratio (HR), 95% confidence
interval (CI), and P value. For all tests, P<.05 was considered significant.
The Statistical Package for Social Sciences software (SPSS, Chicago, Ill)
was used.RESULTS
The 30-day mortality rate was 6.0% (18 patients) overall,
8.4% (11 patients) in the UT group, and 4.2% (7 patients)
in the T group (P ¼ NS). The 2-year survival rate was
87.0%  2.7% and 83.6%  3.3% (P ¼ NS), and the
survival rate stratified by New York Heart Association class
I-II was 83.6% 3.1% and 79.2% 3.7% (P¼NS) in the
T and UT groups, respectively.
The 256 survivors included in the present study under-
went an echocardiographic examination at a mean follow-
up of 13  8 months, 14  8 months for the T group and
12  7 months for the UT group (P ¼ .038). The echocar-
diographic modifications are listed in Table 4.
The preoperative mean FTR grade was 1.11 0.32 in the
UT group and 2.11 0.92 in the T group (P<.001). At dis-
charge from the hospital, the mean FTR grade had not de-
creased significantly in the UT group (0.87  0.49,
P ¼ NS) but had significantly decreased in the T group
(0.45  0.36, P<.001). At follow-up, the mean FTR grade
had returned to the preoperative values in the UT group
(1.03  0.57) but had remained similar to the early postop-
erative values in the T group (0.48  0.32).
Only 18 patients (16.4%) in the UT group had FTR grade
0 compared with 83 (56.8%) in the T group (P<.001). A
total of 24 patients had FTR grade 2 or greater, 16
(14.5%) in the UT group and 8 (5.5%) in the T grouprdiovascular Surgery c Volume 142, Number 2 309
TABLE 1. Preoperative characteristics
UT group
(n ¼ 131)
T group
(n ¼ 167)
P
value
Age (y) 66  11 63  12 NS
Female gender 54 (41.5) 74 (44.3) NS
Functional MR 73 (55.7) 55 (33.0) < .001
Ischemic MR 59 (45.0) 32 (19.2) < .001
Nonischemic MR 14 (10.7) 23 (13.8) NS
Structural MR 37 (28.2) 70 (41.9) < .001
MV stenosis 17 (13.0) 42 (25.1) .009
MV prosthesis dysfunction 4 (3.1) 0 .036
Mean NYHA class 2.5  0.7 2.4  0.7 NS
Atrial fibrillation 18 (13.7) 77 (46.1) < .001
Logistic EuroSCORE 8.9% 7.9% NS
TR 1þ 115 (87.8) 59 (35.3) < .001
TR 2þ 12 (9.2) 52 (31.1) < .001
TR 3þ 3 (2.3) 45 (26.9) < .001
TR 4þ 1 (0.8) 11 (6.6) < .001
TV annulus in diastole (mm) 32  4 37  5 < .001
TV annulus in systole (mm) 25  4 31  4 .001
Tenting area (cm2) 1.15  0.35 1.36  0.27 < .001
TVCD (mm) 2.89  0.65 3.45  0.47 < .001
RVD (mm) 28  3 31  5 .003
TAPSE (mm) 19  4 17  4 .034
SPAP (mm Hg) 35  11 44  14 .011
EF (%) 48  11 47  13 NS
EDD (mm) 54  13 54  10 NS
ESD (mm) 37  11 38  9 NS
UT, Untreated; T, treated; NS, not significant; MR, mitral regurgitation; MV, mitral
valve; NYHA, New York Heart Association; TR, tricuspid regurgitation; TV, tricuspid
valve;CD, coaptation depth; RVD, right ventricular diameter; TAPSE, tricuspid annu-
lar plane systolic excursion; SPAP, systolic pulmonary artery pressure; EF, ejection
fraction; EDD, end-diastolic diameter; ESD, end-systolic diameter. Data presented
as mean  SD or n (%).
TABLE 3. Echocardiographic-based indications for treatment of
functional tricuspid regurgitation
FTR
Systolic TA grade (apical 4-chamber view)
24 mm 25–28 mm >28 mm
Mild No surgery De Vega Band
Moderate or greater De Vega?* De Vega Band
FTR, functional tricuspid regurgitation; TA, tricuspid annulus. *No patient had FTR
of moderate or greater and TA grade of 24 mm.
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versus 3 patients in the UT group. Globally, the FTR grade
increased in 12 patients (10.9%) in the UT group compared
with none in the T group (P<.001).
Of the 110 patients in the UT group who had undergone
a postoperative echocardiographic examination, 101 had
had mild FTR preoperatively. Of the 101 patients, 31 had
had sysTA of 24 mm or less, and none showed a FTR gradeTABLE 2. Normal echocardiographic values in 20 volunteers
Variable Mean SD Median Minimum Maximum
BS (m2) 1.81 0.16 1.85 1.49 2.16
BMI (kg/m2) 24.3 2.2 24.3 21.0 29.0
Age (y) 41.3 8.8 44 27 53
RV (diastole) (mm) 27.6 1.5 28 24 30
TA (systole) (mm) 24.5 2.0 24 21 28
TA (diastole) (mm) 27.4 2.0 27 24 31
Systolic-diastolic
modification (%)
10.5 3.7 10.3 5.6 20.7
TVCD (mm) 2.76 0.59 2.70 1.80 4.20
Tenting area (cm2) 0.93 0.20 0.88 0.69 1.36
SD, standard deviation; BS, body surface; BMI, body mass index; RV, right ventricle;
TA, tricuspid annulus; TVCD, tricuspid valve coaptation depth.
310 The Journal of Thoracic and Cardiovascular Surgincrease. Of the 70 with a sysTA greater than 24 mm, 7
showed a FTR grade increase to moderate or greater. Of
the 9 patients with a preoperative FTR grade of moderate
or greater, all had had sysTA greater than 24 mm and all
maintained the FTR grade. Cox regression analysis showed
that, in the UT group, a sysTA greater than 24mmwas a risk
factor for a greater FTR grade during follow-up (HR, 2.4;
95% CI, 1.4–5.1; P ¼ .020).
Of the 256 survivors, 24 had a postoperative FTR of grade
2 or more, which was considered an event. Proportional Cox
regression analysis evidenced only 2 risk factors: inclusion
in the UT group (HR, 4.1; 95% CI, 1.7–9.7; P ¼ .002) and
atrial fibrillation persistence at 6 months (HR, 2.0; 95% CI,
1.1–4.6; P ¼ .029). Nevertheless, patients with atrial fibril-
lation persistence had a greater FTR grade in the UT group
(n ¼ 10) than in the T group (n ¼ 33; 1.6  0.7 vs 0.91 
0.63, respectively, P ¼ .005), showing the protective effect
of tricuspid annuloplasty in this subgroup of patients. The
incidence of preoperative atrial fibrillation was greater in
the T group, but it was not a risk factor.
The sysTAwas greater than 28 mm in all patients in the
T group (n ¼ 8) with a follow-up FTR grade of 2 or
more. All 8 patients had undergone De Vega annuloplasty.
This finding supports the concept that a careful analysis
of the echocardiographic anatomy could be crucial for
choosing the correct strategy (band vs De Vega annulo-
plasty) and that De Vega annuloplasty can have suboptimal
results when the sysTA is greater than 28 mm, but not when
it is 28 mm or less.
In the 16 patients in the UT group who had, at follow-up,
a FTR grade of 2 or more, most (10/16) had a sysTA of 25 to
28 mm, supporting the strategy to correct any FTR grade if
the sysTA is 24 mm or greater. The remaining 6 patients had
a sysTA greater than 28 mm. Preoperatively, 7 of these
patients had had FTR grade 1 and 9 had had FTR grade
2 or more.
DISCUSSION
The main findings of the present study were that when
FTR is not treated, the FTR grade will have increased in
10.9% of patients after 1 year. Also, extensive treatment
of FTR of any grade resulted in an early reduction of the
FTR grade that was sustained after 1 year. Third, the echo-
cardiographic TA systolic dimension will be crucial for de-
cision making, because the TA dimensions correlated withery c August 2011
TABLE 4. Echocardiographic modifications in 256 survivors
Variable
UT group (n ¼ 110) T group (n ¼ 146)
Preoperative Postoperative P value Preoperative Postoperative P value
TV annulus in diastole (mm) 31  3 29  3 NS 37  4 26  3 < .001
TV annulus in systole (mm) 25  4 24  3 NS 31  4 22  3 < .001
Tenting area (cm2) 1.0  0.6 0.8  0.6 NS 1.4  0.7 0.7  0.3 < .001
TVCD (mm) 7.2  5.4 7.0  5.5 NS 8.3  3.9 6.3  3.3 < .001
RVD (mm) 28  4 28  6 NS 30  4 28  4 NS
TAPSE (mm) 19  4 15  3 .001 18  4 16  3 NS
SPAP (mm Hg) 34  9 30  8 NS 44  14 32  12 .001
EF (%) 48  7 47  9 NS 44  12 48  11 NS
MR (from 1 to 4) 2.7  1.1 0.4  0.5 < .001 2.9  1.1 0.7  0.9 < .001
TR (from 0 to 4) 1.1  0.4 1.0  0.6 NS 2.0  0.9 0.5  0.6 < .001
No TR 0 18 (16.4) < .001 0 83 (56.8) < .001
TR 1þ 101 (91.8) 76 (69.1) < .001 54 (37.0) 55 (37.7) NS
TR 2þ 7 (6.4) 13 (11.8) NS 45 (30.8) 8 (5.5) < .001
TR 3þ/4þ 2 (1.8) 3 (2.7) NS 47 (32.2) 0 < .001
Follow-up (mo) 12  7 14  8 .038
Abbreviations as in Table 1. Data presented as mean  SD or n (%).
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pulmonary hypertension, the right ventricular dimension,
or tricuspid tenting. Thus, the TA dimensions were the
best FTR determinant.8 Finally, annuloplasty was able to re-
duce the amount of FTR in patients with postoperative atrial
fibrillation.
TR is a common echocardiographic finding. Nath and
colleagues1 evaluated 5223 patients who had undergone
echocardiography at 1 laboratory within a 4-year period.
The TR incidence was 88.5%, with 15.5% having moder-
ate or greater TR. These patients, after adjustment for left
ventricular ejection fraction, inferior vena cava size, and
right ventricular size and function, had a 4-year survival
worse than that of patients without TR.
The evolution of untreated FTR was studied by different
investigators. Dreyfus and colleagues2 corrected the FTR in
311 patients according to the anatomic criteria (intraopera-
tive diameter 70 mm). Before surgery, of the 148 patients
in whom tricuspid annuloplasty was performed, 38 (25.7%)
had no FTR and 92 (62.2%) had grade 1 FTR. After a mean
follow-up of 4.8 years, the FTR grade had changed from
0.88 to 0.36 in the treated patients and from 0.82 to 2.07
in the untreated patients (P<.001), with 48% of the pa-
tients having an increase to FTR grade 2 or more. These
findings had no influence on survival or cardiac event-free
survival. Matsuyama and colleagues9 followed up 174 pa-
tients without FTR repair for a mean of 8.2 years. Of the
174 patients, 24% had had FTR grade 2 and 76% had
had grade 1 or less. During follow-up, 16% had developed
FTR of grade 3 or more. Preoperative FTR grade 2 was
a risk factor for the late development of FTR grade 3 or
more (odds ratio, 3.9; P ¼ .004).
Although untreated FTR can worsen over time and can be
associated with reduced survival, the results of surgical
correction of FTR have not been perfect.The Journal of Thoracic and CaMcCarthy and colleagues10 evaluated 790 patients who
had undergone FTR treatment using different techniques
(rigid complete ring, incomplete band, De Vega, and peri-
cardium) and had echocardiographic reports after a median
of 6 months. They found that residual FTR occurred in 14%
of patients in the first month after operation for all types of
annuloplasty. The FTR grade evolved differently according
to the repair technique. The severity of regurgitation re-
mained stable over time after repair with the complete rigid
ring and with a band, but it increased significantly with the
De Vega and pericardium repair techniques.
Kuwaki and colleagues11 found that 25% of the 194 pa-
tients treated with De Vega annuloplasty had had, in the first
postoperative months, FTR recurrence of a moderate or
greater grade. The risk factor was preoperative FTR grade
4. Fukuda and colleagues12 followed up with sequential
echocardiograms in 39 patients, who had undergone differ-
ent annuloplasty techniques. Of the 39 patients, 23% devel-
oped moderate or greater FTR recurrence in the first
postoperative month and 31% after 20 months. The risk
factors for late FTR return were reduced postoperative
left ventricular function (cutoff value, 36.6%), early post-
operative FTR (cutoff value for maximal TR area/right
atrial area ratio greater than 0.13). These investigators intro-
duced an interesting concept, because they found preopera-
tive tenting height (cutoff value, 0.51 cm) and preoperative
tenting area (cutoff value, 0.80 cm2) to be risk factors for
FTR. They emphasized that the cause of FTR return could
be a ventricular factor and not technical failure. Although
the TV coaptation depth was coherent with our measures
(Tables 1 to 3), the tenting area was smaller than we
measured, very likely because of technical issues.
De Vega annuloplasty has been found in different reports
to be a technical risk factor for FTR return.13,14 Our
personal experience15 did not confirm these results. Twordiovascular Surgery c Volume 142, Number 2 311
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of moderate or more, underwent MV surgery for functional
mitral regurgitation. In the first group, the FTR was treated
(De Vega annuloplasty) and in the second was untreated. At
1 year after surgery, the FTR grade had decreased in the
treated group from 3.1  0.7 to 0.7  0.7 (P < .001)
and had remained stable in the untreated group (from
2.2  0.4 to 2.3  0.9, P ¼ NS). Thus, De Vega annulo-
plasty provided good midterm results.
The published data have suggested that moderate or
greater FTR is a risk factor for survival and that any grade
of FTR can worsen over time, independently of the initial
grade. However, the results of De Vega suture annuloplasty
have been debatable, with most studies showing a greater
incidence of FTR recurrence compared with device-based
annuloplasty. Finally, early recurrence of FTR seems to
be frequent, irrespective of the technique used.
These findings pushed us to a more aggressive approach
for FTR correction, determined mainly from the preopera-
tive TA echocardiographic systolic dimensions. Regarding
functional mitral regurgitation, we believe that the systolic,
rather than the diastolic, dimensions of the TA are helpful in
decision making, because FTR occurs during systole. We
decided to also correct mild FTR, because it was evident
from the results from Dreyfus and colleagues,2 that, even
in a population of patients with low-grade or no FTR, the
possibility of the FTR worsening over time is high. The cor-
relation between residual FTR and the persistence of atrial
fibrillation is well known16; nevertheless, tricuspid annulo-
plasty is able to reduce its progression.
We believe that TA dilation, by itself, cannot be the only
determinant of the surgical indication. In fact, 65% of pa-
tients without TA dilation (mean systolic TA dimension
25.4  3.2) can have FTR grade 1 or 217 and are a part of
a subgroup whose natural history is worse than that of pa-
tients without FTR. Chopra and colleagues18 found that in
patients with nonsevere FTR (jet area/right atrium area
ratio<33%; mean, 27.5  6.9), the mean TA diastolic di-
mension was 17.8  2.5 mm. This value was equivalent to
roughly 32 mm in a normal patient, 1 mm more than the
maximal value we found in our normal population (Table
2). Thus, many patients can have significant FTR even if
the TA dimensions are within the normal range.
In agreement with these published data, we found that
most of the patients in the UT group who, during follow-
up, had an FTR grade of moderate or greater still had
a sysTAwithin the normal range (25–28 mm). This finding
justifies our strategy to correct FTRwhen the sysTA is in the
higher normal range (> 24 mm). In contrast, the patients
with sysTA of 24 mm or less did not show any increase in
FTR grade, at least in the midterm.
De Vega annuloplasty (not limited to the posteroseptal
commissure but extended to the insertion of the septal
leaflet in front of the coronary sinus) can reasonably be312 The Journal of Thoracic and Cardiovascular Surgperformed in patients with a less dilated sysTA ( 28 mm);
however, in patients with a more dilated sysTA (>29 mm),
it is very likely that band annuloplasty would be the best op-
tion. This speculation was supported by the retrospective
analysis of patients in the T group with a postoperative
FTR grade of 2 or greater. All these had undergone De
Vega annuloplasty and had a sysTA greater than 29 mm.
However, no patients who had undergone De Vega annulo-
plasty and sysTA of 28 mm or less showed FTR grade pro-
gression. This solution can be cost effective, because it
allows the expansion of the indications for TVannuloplasty
without the necessity of using a band in every case.
The TV coaptation depth evaluation, a new concept intro-
duced by Fukuda and colleagues,12 can be useful in the de-
cision making of tricuspid surgery. Very likely, techniques
different from those commonly used are needed,19,20 even
if the problem is not yet well defined.
Study Limitations
The present study was retrospective, the subgroup popu-
lation was small, and the follow-up was relatively short.
These were its main limitations. Moreover, the differences
in the postoperative FTR grade were small and potentially
clinically irrelevant. The 2 groups were also different; how-
ever, the New York Heart Association class, ejection frac-
tion, and left ventricular dimensions were similar, and in
every case, the cause of FTR was functional. Moreover,
more patients in the UT group had functional mitral regur-
gitation, but the systolic pulmonary artery pressure and
right ventricular dimensions were lower than those in the
T group. In contrast, group T had a greater incidence of pre-
operative atrial fibrillation. However, Cox analysis did not
identify either the etiology of mitral disease or preoperative
atrial fibrillation as a risk factor. Nevertheless, we cannot
foresee the change in FTR grade in the long term when
stratified by the etiology of the MV disease, even if progres-
sion of FTR, if untreated, was reported after surgery for
both mainly structural2 and functional15 MV disease. An-
other important point is that the concept that surgical treat-
ment of a low FTR grade could improve, in the long term,
the clinical results is only speculative and was not supported
by the data from our short follow-up.
CONCLUSIONS
We believe that aggressive correction of FTR can be
helpful in reducing, in the midterm, the FTR grade, because
in patients with preoperative FTR, even of low grade, mitral
surgery alone was not able to eliminate or reduce the FTR
grade. In the UT group, 10.9% of patients had a worsened
FTR grade and only 12.7% of them had no FTR. In contrast,
in the T group, no patient had a worsened FTR grade and
61.0% had no FTR, even if the preoperative FTR grade
had been greater than in the UT group. We believe that pre-
operative echocardiographic evaluation of the TA systolicery c August 2011
Calafiore et al Acquired Cardiovascular Diseasedimensions will be helpful to both select patients who need
FTR treatment and the proper surgical strategy (Table 3).
However, at least in the midterm, the clinical outcomes
were not influenced by the surgical strategy.
The natural history of untreated FTR is one of progres-
sive worsening over time, even if the preoperative FTR
grade was mild.2 Limiting this unfavorable outcome, be-
cause the surgical procedure is rapid and effective, must
be our goal during MV surgery.A
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